Stay updated on Nivolumab for ALK+ ALCL: Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for ALK+ ALCL: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for ALK+ ALCL: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page’s revision tag has been updated from v3.5.3 to v3.5.4, indicating a minor update to the page's metadata rather than a change to study content.
    Difference
    0.1%
    Check dated 2026-05-16T10:19:49.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.5.2 to v3.5.3, reflecting a content management/versioning update rather than changes to the clinical study details.
    Difference
    0.1%
    Check dated 2026-04-24T22:20:45.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No visible content changes are indicated.
    Difference
    0.1%
    Check dated 2026-04-17T13:52:54.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The Locations section was updated with new entries for Paris and Villejuif in Val-de-Marne, and some existing address lines were removed or reformatted.
    Difference
    0.9%
    Check dated 2026-04-03T05:31:33.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Only minor layout and wording tweaks observed; core study information remains unchanged.
    Difference
    0.1%
    Check dated 2026-03-27T01:41:14.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    Page revision updated: v3.4.3 replaced with v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T22:17:09.000Z thumbnail image

Stay in the know with updates to Nivolumab for ALK+ ALCL: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for ALK+ ALCL: Clinical Trial page.